Hirsch, Joshua A. https://orcid.org/0000-0002-9594-8798
Gilligan, Christopher
Chandra, Ronil V.
Brook, Allan
Gasquet, Nicolas C.
Ricker, Christine N.
Wu, Charlotte
Article History
Received: 25 April 2024
Accepted: 18 October 2024
First Online: 23 November 2024
Declarations
:
: This was an observational study of de-identified data. Sterling IRB (Atlanta, GA, USA) has determined that the study is exempt from full IRB review. Formal consent for this retrospective study was not required. Sterling IRB (Atlanta, GA, USA) has determined that no patient consent to participate was required.
: NCG, CNR and CW are current employees of Medtronic. JAH was a consultant for Medtronic, Relievant, and Cerenovus in the last 12 months, and provided DMC and DSMB chair work for Rapid Medical, Balt, and Arsenal in the last 12 months. JAH’s effort is supported in part by a grant from the Harvey L. Neiman Health Policy Institute. CG consulted for Mainstay, Persica, Saluda, Iliad Lifesciences, Biotronik, and Presidio; has stock options with Mainstay; is on the board of directors of the International Neuromodulation Society; and is Editor-in-Chief of <i>Pain Practice</i>. AB was an advisor for Medtronic, NEVRO, and Boston Scientific. RVC declares no competing interests.